Argenx SE ADS (ARGX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

INDUSTRIEPARK ZQIJNAARDE 7 ZWIJNAARDE, BELGIUM B-9052

Argenx SE operates as a biotechnology company. The Company develops antibody based therapies for the treatment of severe autoimmune diseases and cancer. argenx serves customers in the Netherlands and Belgium.

Data based on most recent fiscal year report
Market Cap2.473 Billion Shares Outstanding32.17 Million Avg Volume137.595 Thousand
1-Yr BETA vs S&P TR Current Ratio2.4 Quick Ratio2.4
View SEC Filings from ARGX instead.
Q4 2017 All Institutions Hedge Funds 1
To trade ARGX now:
Filers who had this stock in their top 10: 5 4 (0.37%)
13F Filers holding this stock: 65 31 (2.87%)
Aggregate 13F shares on 12/31/2017: 14.459 Million 7.567 Million
Aggregate 13F shares on 09/30/2017: 6.946 Million 3.165 Million
Percent change: 108.18% 139.07%
Funds creating new positions: 35 15
Funds Adding to an existing position: 20 9
Funds closing out their position: 3 1
Funds reducing their position: 5 4
1 hedge funds as identified by whalewisdom.com through public filings.

Funds Holding ARGX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to

Exclude:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Acquired or Disposed Shares Owned Following Transaction Direct/Indirect Ownership
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments